EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists

Melissa D Chengalroyen, Nurudeen Oketade, Aneta Worley, Megan Lucas, Luisa Maria Nieto Ramirez, Mabule L Raphela, Gwendolyn M Swarbrick, Paul S Soma, Mandisa Zuma, Digby F Warner, Deborah A Lewinsohn, Carolina Mehaffy und 5 weitere

PLOS Pathogens · 01.07.2025 · 21 (7) · e1012632

DOI: 10.1371/journal.ppat.1012632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 01.07.2025. Verfasst von Melissa D Chengalroyen und 16 weiteren Autor:innen. Beteiligte Einrichtung: UCT Molecular Mycobacteriology Research Unit, Institute of Infectious Disease and Molecular Medicine & Department of Pathology, University of Cape To…. Hauptthemen laut MEDLINE: Riboflavin, Mucosal-Associated Invariant T Cells, Mycobacterium tuberculosis, Mycobacterium smegmatis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Gates Foundation, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal-associated invariant T (MAIT) cells exhibit an intrinsic ability to recognize and respond to microbial infections. The semi-invariant antigen recognition receptor of MAIT cells specifically detects the non-polymorphic antigen-presenting molecule, major histocompatibility complex class I-related protein 1 (MR1), which primarily binds riboflavin-derived metabolites of microbial origin. To further interrogate the dependence of these antigens on riboflavin biosynthesis in mycobacteria, we deleted individual genes in the riboflavin biosynthesis pathways in Mycobacterium smegmatis (Msm) and Mycobacterium tuberculosis (Mtb) and evaluated the impact thereof on MAIT cell activation. Blocking the early steps of the pathway by deletion of RibA2 or RibG profoundly reduced, but did not completely ablate, MAIT cell activation by Msm or Mtb, whereas deletion of RibC, which catalyzes the last step in the pathway, had no significant effect. Interestingly, deletion of the lumazine synthase (RibH) specifically enhanced MAIT cell recognition of Mtb whereas loss of lumazine synthase activity had no impact on MAIT cell activation by Msm. MAIT cell activation by Msm was likewise unaffected by blocking the production of the MAIT cell antagonist, F o (by inhibiting its conversion from the riboflavin pathway intermediate, 5-amino-6-D-ribitylaminouracil (5-A-RU), through the deletion of fbiC ). Together, these results confirm a central role for 5-A-RU in generating mycobacterial MR1 ligands and reveal similarities and differences between Msm and Mtb in terms of the impact of riboflavin pathway disruption on MAIT cell activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RiboflavinMucosal-Associated Invariant T CellsMycobacterium tuberculosisMycobacterium smegmatisLymphocyte ActivationHumansAnimalsMiceHistocompatibility Antigens Class I

Substanzen

RiboflavinHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • UCT Molecular Mycobacteriology Research Unit, Institute of Infectious Disease and Molecular Medicine & Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
  • Department of Pulmonary, Allergy & Critical Care Medicine, Oregon Health and Science University, Portland, Oregon, United States of America.
  • Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa.
  • Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, United States of America.
  • Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, United States of America.

Förderung

  • BLRD VA
  • Gates Foundation
  • NIAID NIH HHS
  • Ernest Oppenheimer Memorial Trust
  • Bill and Melinda Gates Foundation
  • Broad Institute
  • South African Medical Research Council
  • National Research Foundation

Zitieren

APA

Chengalroyen, M. D., Oketade, N., Worley, A., Lucas, M., Ramirez, L. M. N., Raphela, M. L., Swarbrick, G. M., Soma, P. S., Zuma, M., Warner, D. F., Lewinsohn, D. A., Mehaffy, C., Adams, E. J., Hildebrand, W., Dobos, K. M., Mizrahi, V., & Lewinsohn, D. M. (2025). Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists. PLOS Pathogens, 21(7), e1012632. https://doi.org/10.1371/journal.ppat.1012632

Vancouver

Chengalroyen MD, Oketade N, Worley A, Lucas M, Ramirez LMN, Raphela ML, et al. Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists. PLOS Pathogens. 2025;21(7):e1012632. doi:10.1371/journal.ppat.1012632

BibTeX
@article{Chengalroyen2025,
  author = {Chengalroyen, Melissa D and Oketade, Nurudeen and Worley, Aneta and Lucas, Megan and Ramirez, Luisa Maria Nieto and Raphela, Mabule L and Swarbrick, Gwendolyn M and Soma, Paul S and Zuma, Mandisa and Warner, Digby F and Lewinsohn, Deborah A and Mehaffy, Carolina and Adams, Erin J and Hildebrand, William and Dobos, Karen M and Mizrahi, Valerie and Lewinsohn, David M},
  title = {Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists},
  journal = {PLOS Pathogens},
  year = {2025},
  volume = {21},
  number = {7},
  pages = {e1012632},
  doi = {10.1371/journal.ppat.1012632}
}
Kostenlos starten →